SofWave Medical Ltd.
SOFWF
$12.75
$1.8516.97%
OTC PK
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 37.15% | 0.40% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 37.15% | 0.40% | |||
| Cost of Revenue | 27.07% | 7.96% | |||
| Gross Profit | 40.74% | -2.05% | |||
| SG&A Expenses | 28.26% | 0.30% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 26.34% | 4.12% | |||
| Operating Income | 179.37% | -31.71% | |||
| Income Before Tax | 206.81% | -21.79% | |||
| Income Tax Expenses | -143.87% | 129.63% | |||
| Earnings from Continuing Operations | 317.52% | -35.27% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 317.52% | -35.27% | |||
| EBIT | 179.37% | -31.71% | |||
| EBITDA | 120.31% | -22.14% | |||
| EPS Basic | 313.36% | -35.58% | |||
| Normalized Basic EPS | 204.85% | -22.53% | |||
| EPS Diluted | 393.50% | -50.00% | |||
| Normalized Diluted EPS | 203.96% | -22.90% | |||
| Average Basic Shares Outstanding | 0.79% | 0.62% | |||
| Average Diluted Shares Outstanding | 1.04% | 1.26% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||